Martell CEO leads startup's push to commercialize breast cancer blood test
10 May 2021
CEO Michelle Edwards is leading Martell Diagnostic Laboratories' commercialization of its new diagnostic test for managing breast cancer treatment.
Martell raised $2 million from angel investors in a recent Series A round, Edwards said.
The company aims to raise $10 million this year in a Series B round that Edwards hopes will attract institutional investors as well as diagnostics and pharmaceutical companies that invest in venture-backed companies.
The company, which is collaborating with the University of Minnesota and the Moffitt Cancer Center in Florida, soon expects to publish clinical studies that will validate its tests and show doctors what they do and how to use them, Edwards said.
More Topics
There’s a new virtual food court and food truck up and running on the Roseville-St. Paul border.
Tony Delaney, whose barbecue gained fanfare following the rollout of his Pig Approved BBQ food trailer in the fall of 2018, now has a bricks-and-mortar spot in Roseville by that same name...
Like a damaged puzzle piece, one 12-acre parcel of land is all that stands between Roseville and its half-century quest to finish its Twin Lakes development.
A former trucking terminal, the property is a contaminated eyesore that keeps prospective buyers at bay due to its hefty, upfront environmental cleanup...
59 years ago, 1st Target opens in Roseville
May 4 2021Target is celebrating 59 years since their first retail store opened in Minnesota.
On May 1, 1962, the first Target store opened in Roseville. In its posters to advertise the opening, the store stated, "a store you can be proud to shop in, a store you can have confidence in,...
